Pancreatic Cancer Research

ResearcherBengbu Medical CollegeActive in the last 2 years

Jia Ma

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1459-3938; OpenAlex author ID A5004239408. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

  1. FBXO9 promotes anti-tumor immunity via degradation of PD-L1 in pancreatic cancer. Last author DOI 10.3389/fimmu.2025.1726825↗
  2. FBXO31 is upregulated by METTL3 to promote pancreatic cancer progression via regulating SIRT2 ubiquitination and degradation. Last author DOI 10.1038/s41419-024-06425-y↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jun Xia · 2 shared papers, 2024–2025 · strength 0.42
  2. Tong Cao · 1 shared paper, 2025 · strength 0.23
  3. Hua Huang · 1 shared paper, 2025 · strength 0.23
  4. Shangshang Hu · 1 shared paper, 2024 · strength 0.19
  5. Kai Chen · 1 shared paper, 2024 · strength 0.19
  6. Zhiwei Peter Wang · 1 shared paper, 2024 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.